Show simple item record

dc.contributor.author Massicotte, Eric M. en_US
dc.date.accessioned 2007-07-12T17:48:48Z
dc.date.available 2007-07-12T17:48:48Z
dc.date.issued 2000-05-01T00:00:00Z en_US
dc.identifier.uri http://hdl.handle.net/1993/2553
dc.description.abstract We nvestigated two drugs, nimodipine and AXOKINE(R), and their effect on functional outcome in an infant rat model of experimental hydrocephalus. Hydrocephalus was achieved by injecting kaolin into the cisterna magna of three-week-old rats. Hydrocephalus was allowed to develop for two weeks prior to beginning treatment with nimodipine subcutaneously (1.8 mg per day) for 14 days at which time the rats were killed. The rats in this group were not surgically treated with shunting. In a separate experiment hydrocephalus was allowed to progress for three weeks. The rats were then shunted and intraventricular administration of a second generation ciliary neurotrophic factor, AXOKINE (R) at either a low dose (1.4 [mu]g/day) or high dose (14.3 [mu]g/day) was started. Functional assessment consisted of motor, memory and learning components. Motor function was tested using spontaneous activity counting, ability to stay on a rotating drum, and swimming. Memory and learning were quantitatively monitored using a modified Morris water maze. Histological examination provided pathological correlates to the functional outcome. (Abstract shortened by UMI.) en_US
dc.format.extent 4276186 bytes
dc.format.extent 184 bytes
dc.format.mimetype application/pdf
dc.format.mimetype text/plain
dc.language en en_US
dc.language.iso en_US
dc.title Adjunctive drug therapy for treatment of experimental hydrocephalus en_US
dc.degree.discipline Surgery en_US
dc.degree.level Master of Science (M.Sc.) en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

View Statistics